← FDA DRUG APPROVALS

FDA ANDA · ANDA085034

ALPHAZINE

Sponsor: SANDOZ

APPLICATION
ANDA085034
TYPE
ANDA
ORIGINAL APPROVAL
1978-04-19
LATEST ACTION
1991-10-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ALPHAZINEDiscontinued
PHENDIMETRAZINE TARTRATE 35MG · TABLET · ORAL

Approval history

1991-10-10Labeling · Supplement 13AP
1991-02-20Labeling · Supplement 12AP
1989-10-24Labeling · Supplement 11AP
1985-06-13Manufacturing (CMC) · Supplement 10AP
1982-09-24Manufacturing (CMC) · Supplement 7AP
1982-08-30Manufacturing (CMC) · Supplement 6AP
1978-04-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →